Engineering advanced bacterial therapy for tumor and inflammatory diseases

Area of Science:

• Biomedicine
• Synthetic Biology
• Materials Science

Background:

• Engineered bacteria are emerging as a promising living medicine.
• Advancements in synthetic biology and materials science create new opportunities for bacterial therapy.
• Engineered bacteria offer genetic reprogramming and surface modification for enhanced therapeutic control.

Purpose of the Study:

• To review the advantages and engineering strategies of engineered bacterial therapy.
• To summarize studies on engineered bacterial therapy for tumors and inflammatory diseases.
• To explore the potential of oral engineered bacteria for gastrointestinal diseases.

Main Methods:

• Review of current literature on engineered bacterial therapy.
• Analysis of genetic reprogramming and surface chemistry modification strategies.
• Examination of case studies in tumor and inflammatory disease treatment.

Main Results:

• Engineered bacterial therapy demonstrates enhanced efficacy through selective functional recombination and spatiotemporal control.
• Diverse engineered approaches show promise in treating tumors and inflammatory diseases.
• Oral engineered bacteria present novel avenues for gastrointestinal disease management.

Conclusions:

• Engineered bacterial therapy holds significant potential for disease management.
• Further innovation is needed to address current limitations and challenges.
• Oral engineered bacteria show specific promise for gastrointestinal tumors and inflammatory diseases.